Ingrid Goldberg

Ingrid Goldberg currently serves as Vice President of Finance and Investor Relations at Novocure, a role held since July 2021. Prior to this position, Ingrid was Vice President of Investor Relations at bluebird bio from January 2020 to June 2021 and held the title of Head of Investor Relations at Abiomed from September 2014 to December 2019. Ingrid's earlier experience includes various roles at Bank of America Merrill Lynch, where responsibilities included Convertible Bond Trading, Convertible Bond Sales, and Equity Capital Markets from June 2005 to March 2014. Ingrid holds an MBA from the MIT Sloan School of Management and has a degree from Princeton University.